Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1Phase 1 1

Status

Completed 30Unknown 5Terminated 5Recruiting 3Suspended 2Not yet recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Pain 2Neoplasms 2Lung Neoplasms 1Cancer Pain 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Oxycodone × Clear all
NCT05742256 2023-02-23

Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer

Qianfoshan Hospital

Phase 1 Unknown
159 enrolled
Thoracic

Lung Neoplasms

NCT04808531 2022-04-12

NanaBisâ„¢ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers

Medlab Clinical

Phase 3 Unknown
360 enrolled

Cancer Pain

NCT03564548 2021-07-28

REBORN

Tetra Bio-Pharma

Phase 2 Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

NCT02084355 2014-03-12

Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain

Gyeongsang National University Hospital

Phase 3 Unknown
136 enrolled

Neoplasms, Pain

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown
500 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡